Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma in vivo.

about

Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma in vivo.

Item

http://www.wikidata.org/entity/Q55265829

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Surgical thyroparathyroidectom ...... rine multiple myeloma in vivo.

@en

Surgical thyroparathyroidectom ...... rine multiple myeloma in vivo.

@nl

type

Item

label

Surgical thyroparathyroidectom ...... rine multiple myeloma in vivo.

@en

Surgical thyroparathyroidectom ...... rine multiple myeloma in vivo.

@nl

prefLabel

Surgical thyroparathyroidectom ...... rine multiple myeloma in vivo.

@en

Surgical thyroparathyroidectom ...... rine multiple myeloma in vivo.

@nl

P1476

Surgical thyroparathyroidectom ...... rine multiple myeloma in vivo.

@en

P2093

Donghoon Yoon

http://www.w3.org/2001/XMLSchema#string

Hanna Yoo

http://www.w3.org/2001/XMLSchema#string

Ik Jae Shin

http://www.w3.org/2001/XMLSchema#string

Larry J Suva

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoblastic cells regulate the haematopoietic stem cell niche

Serum parathyroid hormone is a new potential risk factor in multiple myeloma

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

The effects of proteasome inhibitors on bone remodeling in multiple myeloma.

Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL

A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients.

Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease.

A murine model of myeloma that allows genetic manipulation of the host microenvironment.

Parathyroid hormone receptor mediates the anti-myeloma effect of proteasome inhibitors.

A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease.

P304

19-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JBO.2018.02.005

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Zangari

P577

2018-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29556454

http://www.w3.org/2001/XMLSchema#string

P932

5854927

http://www.w3.org/2001/XMLSchema#string